Compliance & Validation — Documented
SOC 2 Type II, HIPAA
Trial Library
AI platform delivering clinical trials as a care option to expand equitable access to precision oncology.
Trial Library, founded in 2022 and headquartered in San Francisco, California, builds an AI platform that helps deliver clinical trials as a care option, working with biopharma manufacturers, payers, and health systems to expand equitable access to precision oncology. The company raised a $10M Series A. Trial Library documents on its own site that it has achieved SOC 2 Type 2 (third-party audited with no noted exceptions) and HIPAA compliance.
- Headquarters
- San Francisco, United States
- Founded
- 2022
- Compliance
- SOC 2 Type II, HIPAA
- Deployment options
- cloud
- Website
- https://www.triallibrary.com
- https://www.linkedin.com/company/triallibrary
Categories
AI Use Cases
- Patient Recruitment & Enrollment
Vendor Scorecard
64% — Partial coverage. Coverage score — how completely Atlas documents Trial Library across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Not documented by Atlas
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Implementation & Onboarding — Not documented by Atlas
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Organization & Role Fit — Documented
Mid-Size Biotech, Large Pharma, Top 20 Pharma, Clinical Operations, Medical Affairs
Solution Scope — Documented
Natural Language Processing, Patient Recruitment
Company Viability — Partially documented
Series A, Founded 2022
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Questions to Ask This Vendor
- How does the platform surface trial options within an oncology care workflow?
- What data sources drive patient-trial matching for our indications?
- Can you share the current SOC 2 Type 2 report under NDA?
- Which health-system or sponsor partnerships can serve as references?